Institut des Maladies de l'Appareil Digestif, Nantes University Hospital, France; Institut National de la Santé et de la Recherche Médicale U954 and Department of Gastroenterology, Nancy University Hospital, University of Lorraine, France.
University of California San Diego, La Jolla, California.
Gastroenterology. 2020 Jan;158(1):76-94.e2. doi: 10.1053/j.gastro.2019.08.058. Epub 2019 Oct 5.
Since 2010, substantial progress has been made in artificial intelligence (AI) and its application to medicine. AI is explored in gastroenterology for endoscopic analysis of lesions, in detection of cancer, and to facilitate the analysis of inflammatory lesions or gastrointestinal bleeding during wireless capsule endoscopy. AI is also tested to assess liver fibrosis and to differentiate patients with pancreatic cancer from those with pancreatitis. AI might also be used to establish prognoses of patients or predict their response to treatments, based on multiple factors. We review the ways in which AI may help physicians make a diagnosis or establish a prognosis and discuss its limitations, knowing that further randomized controlled studies will be required before the approval of AI techniques by the health authorities.
自 2010 年以来，人工智能（AI）及其在医学领域的应用取得了重大进展。AI 技术被用于胃肠道疾病的内镜下病变分析、癌症检测，以及无线胶囊内镜检查中对炎症性病变或胃肠道出血的辅助分析。AI 还被用于评估肝纤维化，并区分胰腺癌患者和胰腺炎患者。AI 还可以基于多种因素来评估患者的预后或预测他们对治疗的反应。我们回顾了 AI 帮助医生做出诊断或建立预后的方法，并讨论了其局限性，因为在卫生当局批准 AI 技术之前，还需要进行更多的随机对照研究。
